When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Zacks.com on MSN4h
Novo Nordisk Stock Plunges 18% in a Week: What Should Investors Do?Novo Nordisk NVO shares have plunged 17.9% in a week due to poorer-than-expected efficacy data from a late-stage study of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback